MBOT stock: buy or sell?
September 20th, 2019
Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops next generation micro-robotics assisted medical technologies targeting the minimally invasive surgery space.
Should I buy MBOT stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best time to buy them. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
None of our preferred buy setups matches with Microbot Medical stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Microbot Medical stock a buy?
Banks and financial institutions post stock ratings everyday.At Stocks2.com, we collected 3 ratings published for MBOT stock in the last month.
|Date||Analyst / Broker||Previous rating||Current rating|
MBOT stock analysis
Microbot Medical ended today at $6.55 and remained stable a slightly good 0.31%.
Microbot Medical shares remained stable 0.31% to $6.55 today. On September/18 MBOT price bounced up over the SMA of 200 days demonstrating to be a significant support for this stock.
After sliding a bloodcurdling -12.60% in a week last week, Microbot Medical closed this week at $6.55 and escalated an impressive 4.47%. Early September MBOT boosted an amazing 23.94% in just one week.
In a weekly time frame, Microbot Medical stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, MBOT might consolidate in a flat-base, waiting to break out over or down under . Since price and SMA40w lines crossed up this week, MBOT climbed $0.28 (4.47%).
MBOT stock price history
MBOT stock went public on May 2nd, 2003 with a price of $33,210.001. Since then, MBOT stock declined a -100.00%, with a yearly average of -6.30%.
1: Adjusted price after possible price splits or reverse-splits.
MBOT stock historical price chart
MBOT stock reached 52-week highs on January at $19.40, and all-time highs 2005-01-19 with a price of 109674.
MBOT stock price target is $10.00How much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. We detected 2 price predictions for Microbot Medical stock posted in the last month:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter posting its last earnings report on March, Microbot Medical . As soon as we get its posted EPS from the earnings report, we will extend this report.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2014, last anual sales report draw a scary slide of -88.45% to $0.12 million dollars. When comparing 2015 vs 2014, in line, profit margin (that is, the net income divided by revenues) plunged a -27,919.96% to -31,154.02%.
|2012||$1.37 M||-||$-28.49 M-2079.6%||-|
|2013||$1.20 M||-12.41%||$-26.44 M-2203.3%||-7.20%|
|2014||$1.01 M||-15.63%||$-32.74 M-3234.1%||23.83%|
|2015||$0.12 M||-88.45%||$-36.42 M-31154.0%||11.22%|
Quarterly financial resultsReported quarter earnings marked $-2.13 million with a profit margin of . Profit margin stayed stable a 0.00% compared to previous quarter when profit margin was inf%. When comparing turnover to same quarter last year, Microbot Medical sales marked a tight move and remained stable a nan%. Looking back to recent quarterly results, Microbot Medical posted 7 negative quarters in a row.
Microbot Medical ownershipWhen you are planning to buy shares of a company, it's worth to review its ownership structure.
Microbot Medical shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 20.62% of all shares.
In case of Microbot Medical stock, 15.88% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for MBOT stock account 0.00%, no big difference from last month.
For a better understanding, the following table shows ownership data compared to other related companies:
|Market cap||$28.2 M|
|Total shares||4.3 M|
|Float shares||3.7 M|
|- Institutional holdings (%)||15.9%|
|- Insider holdings (%)||20.6%|
|Shares in short selling||0.0%|
|Friday, September 20th, 2019|
|Day range||$6.47 - $6.63|
|Average true range||$0.66|
|50d mov avg||$5.91|
|100d mov avg||$5.90|
|200d mov avg||$6.30|
Microbot Medical performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We chose as the bechmarking frame for Microbot Medical stock.